30 research outputs found
ΠΠ΅Ρ Π°Π½ΡΠ·ΠΌΠΈ ΡΡΠ°ΡΡΡ ΡΡΠ·ΡΠΎΠ»ΠΎΠ³ΡΡΠ½ΠΎΡ ΡΠΈΡΡΠ΅ΠΌΠΈ ΡΠΏΠΎΠ»ΡΡΠ½ΠΎΡ ΡΠΊΠ°Π½ΠΈΠ½ΠΈ Ρ ΡΠΎΡΠΌΡΠ²Π°Π½Π½Ρ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΡΡΠ½ΠΈΡ ΠΏΡΠΎΡΠ΅ΡΡΠ²
ΠΠΈΡΠ΅ΡΡΠ°ΡΡΡ ΠΏΡΠΈΡΠ²ΡΡΠ΅Π½Π° Π²ΠΈΡΡΡΠ΅Π½Π½Ρ Π°ΠΊΡΡΠ°Π»ΡΠ½ΠΎΡ ΠΏΡΠΎΠ±Π»Π΅ΠΌΠΈ Π²ΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½Π½Ρ ΡΠΎΠ»Ρ ΡΡΠ΅ΡΠ΅ΠΎΡΠΈΠΏΠ½ΠΈΡ
ΡΠ΅Π°ΠΊΡΡΠΉ ΡΠΏΠΎΠ»ΡΡΠ½ΠΎΡ ΡΠΊΠ°Π½ΠΈΠ½ΠΈ ΡΠΊ ΡΡΠ·ΡΠΎΠ»ΠΎΠ³ΡΡΠ½ΠΎΡ ΡΠΈΡΡΠ΅ΠΌΠΈ Π² ΡΠΎΠ·Π²ΠΈΡΠΊΡ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΡΡΠ½ΠΎΠ³ΠΎ ΠΏΡΠΎΡΠ΅ΡΡ. Π‘ΡΠΎΡΠΌΡΠ»ΡΠΎΠ²Π°Π½Ρ Π·Π°Π³Π°Π»ΡΠ½Ρ ΠΏΡΠΈΠ½ΡΠΈΠΏΠΈ ΠΎΡΡΠ½ΠΊΠΈ ΡΡΠ°Π½Ρ ΡΡΠ·ΡΠΎΠ»ΠΎΠ³ΡΡΠ½ΠΎΡ ΡΠΈΡΡΠ΅ΠΌΠΈ ΡΠΏΠΎΠ»ΡΡΠ½ΠΎΡ ΡΠΊΠ°Π½ΠΈΠ½ΠΈ ΡΠ° Π²ΠΈΠ·Π½Π°ΡΠ΅Π½Π° ΡΡ ΡΠΎΠ»Ρ Ρ ΡΠΎΠ·Π²ΠΈΡΠΊΡ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΡΡΠ½ΠΎΠ³ΠΎ ΠΏΡΠΎΡΠ΅ΡΡ Π² ΠΏΠ°ΡΠ΅Π½Ρ
ΡΠΌΠ°ΡΠΎΠ·Π½ΠΈΡ
ΠΎΡΠ³Π°Π½Π°Ρ
(Π½ΠΈΡΠΊΠΈ, ΠΏΠ΅ΡΡΠ½ΠΊΠ°, ΠΏΡΠ΄ΡΠ»ΡΠ½ΠΊΠΎΠ²Π° Π·Π°Π»ΠΎΠ·Π°) Ρ ΠΊΡΡΡΠΊΠΎΠ²ΡΠΉ ΡΠΊΠ°Π½ΠΈΠ½Ρ. ΠΠΏΠ΅ΡΡΠ΅ Π²ΠΈΠ²ΡΠ΅Π½Π° ΡΠΎΠ»Ρ ΡΠ΅Π³ΡΠ»ΡΡΠΎΡΠ½ΠΎΠ³ΠΎ ΡΠ»ΡΡ
Ρ RANK-RANKL-OPG ΠΏΡΠΈ Π΅ΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠ°Π»ΡΠ½ΠΎΠΌΡ ΠΌΠΎΠ΄Π΅Π»ΡΠ²Π°Π½Π½Ρ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΡΡ Π½ΠΈΡΠΎΠΊ, Π²ΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½Π° ΠΉΠΎΠ³ΠΎ Π°ΠΊΡΠΈΠ²Π°ΡΡΡ ΡΠ° Π½Π°ΡΠ²Π½ΡΡΡΡ Π²Π·Π°ΡΠΌΠΎΠ·Π²'ΡΠ·ΠΊΡ Π· ΠΏΡΠΎ- ΡΠ° ΠΏΡΠΎΡΠΈΠ·Π°ΠΏΠ°Π»ΡΠ½ΠΈΠΌΠΈ ΡΠΈΡΠΎΠΊΡΠ½Π°ΠΌΠΈ, Ρ ΡΠΎΠΌΡ ΡΠΈΡΠ»Ρ ΠΏΠΎΠ·ΠΈΡΠΈΠ²Π½Π° ΠΊΠΎΡΠ΅Π»ΡΡΡΡ ΠΌΡΠΆ RANKL Ρ ΠΏΡΠΎΡΡΠ±ΡΠΎΡΠΈΡΠ½ΠΈΠΌ TGF-Ξ²1 (r = 0,61). ΠΠΈΡΠ²Π»Π΅Π½Ρ Π½ΠΎΠ²Ρ ΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅ΡΠΈΡΠ½Ρ ΠΌΠ΅Ρ
Π°Π½ΡΠ·ΠΌΠΈ ΠΏΠΎΡΡΡΠ΅Π½Π½Ρ ΡΡΠ°Π½Ρ ΠΊΡΡΡΠΊΠΎΠ²ΠΎΡ ΡΠΊΠ°Π½ΠΈΠ½ΠΈ, ΡΠΎΠ·Π²ΠΈΡΠΊΡ ΡΡΠ±ΡΠΎΠ·Ρ ΠΏΠ΅ΡΡΠ½ΠΊΠΈ ΡΠ° ΠΏΡΠ΄ΡΠ»ΡΠ½ΠΊΠΎΠ²ΠΎΡ Π·Π°Π»ΠΎΠ·ΠΈ, ΠΏΠΎΠ²'ΡΠ·Π°Π½Ρ Π·Ρ Π·Π½ΠΈΠΆΠ΅Π½Π½ΡΠΌ ΡΡΠ½ΠΊΡΡΠΎΠ½Π°Π»ΡΠ½ΠΎΡ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΡΡΠΎΠΌΠ±ΠΎΡΠΈΡΡΠ². ΠΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΎ, ΡΠΎ ΠΌΠ΅Ρ
Π°Π½ΡΠ·ΠΌΠΈ Π³Π΅ΠΌΠΎΡΡΠ°Π·Ρ Π²ΠΏΠ»ΠΈΠ²Π°ΡΡΡ Π½Π° Π°ΠΊΡΠΈΠ²Π°ΡΡΡ ΠΏΡΠΎΠ»ΡΡΠ΅ΡΠ°ΡΠΈΠ²Π½ΠΈΡ
ΠΏΡΠΎΡΠ΅ΡΡΠ² Ρ ΡΠΏΠΎΠ»ΡΡΠ½ΡΠΉ ΡΠΊΠ°Π½ΠΈΠ½Ρ. ΠΠΎΠΆΠ»ΠΈΠ²ΡΡΡΡ ΠΏΠ΅ΡΠ΅Π½Π΅ΡΠ΅Π½Π½Ρ ΠΎΡΡΠΈΠΌΠ°Π½ΠΈΡ
Π΄Π°Π½ΠΈΡ
Π½Π° ΠΎΡΠ³Π°Π½ΡΠ·ΠΌ Π»ΡΠ΄ΠΈΠ½ΠΈ ΡΡΠΎΡΠ½ΡΠ²Π°Π»Π°ΡΡ Π½Π° ΠΊΠ»ΡΠ½ΡΡΠ½ΠΎΠΌΡ ΠΌΠ°ΡΠ΅ΡΡΠ°Π»Ρ. ΠΠΈΡΠ²Π»Π΅Π½Π° ΡΠΎΠ»Ρ ΡΡΠ°Π½Ρ ΡΡΠ·ΡΠΎΠ»ΠΎΠ³ΡΡΠ½ΠΎΡ ΡΠΈΡΡΠ΅ΠΌΠΈ ΡΠΏΠΎΠ»ΡΡΠ½ΠΎΡ ΡΠΊΠ°Π½ΠΈΠ½ΠΈ Ρ ΡΠΎΠ·Π²ΠΈΡΠΊΡ ΡΡΠΊΠ»Π°Π΄Π½Π΅Π½Ρ Ρ ΡΠ΅ΡΠΈΠ΄ΠΈΠ²ΡΠ² Ρ Ρ
Π²ΠΎΡΠΈΡ
Π· Π³ΡΠ΄ΡΠΎΠ½Π΅ΡΡΠΎΡΠΈΡΠ½ΠΎΡ ΡΡΠ°Π½ΡΡΠΎΡΠΌΠ°ΡΡΡΡ Π½ΠΈΡΠΎΠΊ, Π²ΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½Π° Π°ΠΊΡΠΈΠ²Π°ΡΡΡ ΡΠ΅Π³ΡΠ»ΡΡΠΎΡΠ½ΠΎΠ³ΠΎ ΡΠ»ΡΡ
Ρ RANK-RANKL-OPG Ρ Ρ
Π²ΠΎΡΠΈΡ
Π½Π° Π³ΡΠ΄ΡΠΎΠ½Π΅ΡΡΠΎΠ·. ΠΠΎΠΊΠ°Π·Π°Π½Π° Π²Π·Π°ΡΠΌΠΎΠ΄ΡΡ ΡΡΠ·Π½ΠΈΡ
ΠΌΠ΅Ρ
Π°Π½ΡΠ·ΠΌΡΠ² ΡΠ΅Π³ΡΠ»ΡΡΡΡ ΡΡΠ·ΡΠΎΠ»ΠΎΠ³ΡΡΠ½ΠΎΡ ΡΠΈΡΡΠ΅ΠΌΠΈ ΡΠΏΠΎΠ»ΡΡΠ½ΠΎΡ ΡΠΊΠ°Π½ΠΈΠ½ΠΈ ΠΏΡΠΈ ΡΠΎΠ·Π²ΠΈΡΠΊΡ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΡΡ ΠΎΡΠ³Π°Π½ΡΠ² ΠΏΠ°Π½ΠΊΡΠ΅Π°ΡΠΎΠ΄ΡΠΎΠ΄Π΅Π½Π°Π»ΡΠ½ΠΎΡ Π·ΠΎΠ½ΠΈ. ΠΠ° ΠΎΡΠ½ΠΎΠ²Ρ ΠΎΡΡΠ½ΠΊΠΈ ΡΡΠ°Π½Ρ ΡΡΠ·ΡΠΎΠ»ΠΎΠ³ΡΡΠ½ΠΎΡ ΡΠΈΡΡΠ΅ΠΌΠΈ ΡΠΏΠΎΠ»ΡΡΠ½ΠΎΡ ΡΠΊΠ°Π½ΠΈΠ½ΠΈ Π·Π°ΠΏΡΠΎΠΏΠΎΠ½ΠΎΠ²Π°Π½Ρ ΠΌΠ΅ΡΠΎΠ΄ΠΈ ΠΏΡΠΎΠ³Π½ΠΎΠ·ΡΠ²Π°Π½Π½Ρ Ρ
ΡΡΡΡΠ³ΡΡΠ½ΠΈΡ
ΡΡΠΊΠ»Π°Π΄Π½Π΅Π½Ρ ΡΠ° ΡΠ΅ΡΠΈΠ΄ΠΈΠ²ΡΠ² Π·Π°Ρ
Π²ΠΎΡΡΠ²Π°Π½Π½Ρ. ΠΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠΉ ΠΌΠ΅ΡΠ°Π°Π½Π°Π»ΡΠ· ΠΎΡΡΠΈΠΌΠ°Π½ΠΈΡ
Π΄Π°Π½ΠΈΡ
, Π½Π° ΠΎΡΠ½ΠΎΠ²Ρ ΡΠΊΠΎΠ³ΠΎ Π·Π° Π΄ΠΎΠΏΠΎΠΌΠΎΠ³ΠΎΡ ΡΠ°ΠΊΡΠΎΡΠ½ΠΎΠ³ΠΎ Π°Π½Π°Π»ΡΠ·Ρ Π²ΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½Ρ ΠΎΡΠ½ΠΎΠ²Π½Ρ Π³ΡΡΠΏΠΈ ΠΏΠΎΠΊΠ°Π·Π½ΠΈΠΊΡΠ² (ΡΠ°ΠΊΡΠΎΡΡΠ²), ΡΠΊΡ Π²ΡΠ΄ΠΎΠ±ΡΠ°ΠΆΠ°ΡΡΡ ΠΎΡΠ½ΠΎΠ²Π½Ρ Π½Π°ΠΏΡΡΠΌΠΊΠΈ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΡΡΠ½ΠΎΠ³ΠΎ ΠΏΡΠΎΡΠ΅ΡΡ, ΠΎΠΏΠΎΡΠ΅ΡΠ΅Π΄ΠΊΠΎΠ²Π°Π½Ρ ΡΠ΅Π°ΠΊΡΡΡΡ ΡΡΠ·ΡΠΎΠ»ΠΎΠ³ΡΡΠ½ΠΎΡ ΡΠΈΡΡΠ΅ΠΌΠΈ ΡΠΏΠΎΠ»ΡΡΠ½ΠΎΡ ΡΠΊΠ°Π½ΠΈΠ½ΠΈ. ΠΠΎΠΏΠΎΠ²Π½Π΅Π½Ρ Π½Π°ΡΠΊΠΎΠ²Ρ Π΄Π°Π½Ρ ΠΏΡΠΎ ΠΌΠ΅Ρ
Π°Π½ΡΠ·ΠΌΠΈ Ρ
ΡΠΎΠ½ΡΠ·Π°ΡΡΡ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΡΡΠ½ΠΎΠ³ΠΎ ΠΏΡΠΎΡΠ΅ΡΡ ΠΏΡΠΈ Π·Π°Ρ
Π²ΠΎΡΡΠ²Π°Π½Π½ΡΡ
Π½ΠΈΡΠΎΠΊ, ΠΏΠΎΠΊΠ°Π·Π°Π½ΠΎ, ΡΠΎ Π·ΠΌΡΠ½ΠΈ ΡΡΠ½ΠΊΡΡΠΎΠ½Π°Π»ΡΠ½ΠΎΠ³ΠΎ ΡΡΠ°Π½Ρ ΡΠΏΠΎΠ»ΡΡΠ½ΠΎΡ ΡΠΊΠ°Π½ΠΈΠ½ΠΈ ΠΌΠΎΠΆΡΡΡ Π±ΡΡΠΈ ΠΊΡΠ»ΡΠΊΡΡΠ½ΠΎ Π·Π°ΡΡΠΊΡΠΎΠ²Π°Π½Ρ Π½Π°Π²ΡΡΡ Ρ ΡΠ°Π·Ρ ΡΠΏΠΎΠ²ΡΠ»ΡΠ½Π΅Π½ΠΎΠ³ΠΎ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΡΡΠ½ΠΎΠ³ΠΎ ΠΏΡΠΎΡΠ΅ΡΡ Π² Π½Π΅Π²Π΅Π»ΠΈΠΊΠΎΠΌΡ Π·Π° ΠΌΠ°ΡΠΎΡ ΠΎΡΠ³Π°Π½Ρ. ΠΠΎΠΏΠΎΠ²Π½Π΅Π½Ρ Π½Π°ΡΠΊΠΎΠ²Ρ Π΄Π°Π½Ρ ΠΏΡΠΎ ΡΠΎΠ»Ρ ΡΠ° ΡΡΡΠΏΡΠ½Ρ Π·Π°Π»ΡΡΠ΅Π½ΠΎΡΡΡ ΠΏΠΎΡΡΡΠ΅Π½Ρ ΡΠ΅Π³ΡΠ»ΡΡΠΎΡΠ½ΠΎΡ ΡΡΠ½ΠΊΡΡΡ ΡΡΠ·ΡΠΎΠ»ΠΎΠ³ΡΡΠ½ΠΎΡ ΡΠΈΡΡΠ΅ΠΌΠΈ ΡΠΏΠΎΠ»ΡΡΠ½ΠΎΡ ΡΠΊΠ°Π½ΠΈΠ½ΠΈ Ρ ΡΠΎΠ·Π²ΠΈΡΠΎΠΊ Π·Π°Ρ
Π²ΠΎΡΡΠ²Π°Π½Ρ ΡΠ»ΡΠ½ΠΊΠΎΠ²ΠΎ-ΠΊΠΈΡΠΊΠΎΠ²ΠΎΠ³ΠΎ ΡΡΠ°ΠΊΡΡ, Π² ΡΠΎΠΌΡ ΡΠΈΡΠ»Ρ Π΄ΡΠΎΠ΄Π΅Π½Π°Π»ΡΠ½ΠΎΡ Π²ΠΈΡΠ°Π·ΠΊΠΈ. ΠΠΎΠΊΠ°Π·Π°Π½Π° ΡΠΎΠ»Ρ Ρ Π·Π½Π°ΡΠ΅Π½Π½Ρ Π·Π½ΠΈΠΆΠ΅Π½Π½Ρ ΡΡΠ·ΡΠΎΠ»ΠΎΠ³ΡΡΠ½ΠΈΡ
ΡΠ΅Π·Π΅ΡΠ²ΡΠ² ΡΡΠ·ΡΠΎΠ»ΠΎΠ³ΡΡΠ½ΠΎΡ ΡΠΈΡΡΠ΅ΠΌΠΈ ΡΠΏΠΎΠ»ΡΡΠ½ΠΎΡ ΡΠΊΠ°Π½ΠΈΠ½ΠΈ Π΄Π»Ρ Π·Π±ΡΠ»ΡΡΠ΅Π½Π½Ρ ΡΠΈΠ·ΠΈΠΊΡΠ² Π·Π°Ρ
Π²ΠΎΡΡΠ²Π°Π½ΠΎΡΡΡ Π² ΠΏΠΎΠΏΡΠ»ΡΡΡΡ. ΠΠ°ΠΏΡΠΎΠΏΠΎΠ½ΠΎΠ²Π°Π½ΠΎ ΠΌΠ΅ΡΠΎΠ΄ ΠΎΡΡΠ½ΠΊΠΈ ΡΠΈΠ·ΠΈΠΊΡΠ² Π΄Π»Ρ ΠΏΠΎΠΏΡΠ»ΡΡΡΠΉΠ½ΠΎΠ³ΠΎ Π·Π΄ΠΎΡΠΎΠ²'Ρ Π½Π°ΡΠ΅Π»Π΅Π½Π½Ρ Π½Π° ΠΎΡΠ½ΠΎΠ²Ρ Π°Π½Π°Π»ΡΠ·Ρ ΡΡΠ·ΡΠΎΠ»ΠΎΠ³ΡΡΠ½ΠΈΡ
ΡΠ΅Π·Π΅ΡΠ²ΡΠ² ΡΡΠ·ΡΠΎΠ»ΠΎΠ³ΡΡΠ½ΠΎΡ ΡΠΈΡΡΠ΅ΠΌΠΈ ΡΠΏΠΎΠ»ΡΡΠ½ΠΎΡ ΡΠΊΠ°Π½ΠΈΠ½ΠΈ.ΠΠΈΡΡΠ΅ΡΡΠ°ΡΠΈΡ ΠΏΠΎΡΠ²ΡΡΠ΅Π½Π° ΡΠ΅ΡΠ΅Π½ΠΈΡ Π°ΠΊΡΡΠ°Π»ΡΠ½ΠΎΠΉ ΠΏΡΠΎΠ±Π»Π΅ΠΌΡ β ΡΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΈΡ ΡΠΎΠ»ΠΈ ΡΡΠ΅ΡΠ΅ΠΎΡΠΈΠΏΠ½ΡΡ
ΡΠ΅Π°ΠΊΡΠΈΠΉ ΡΠΎΠ΅Π΄ΠΈΠ½ΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΡΠΊΠ°Π½ΠΈ ΠΊΠ°ΠΊ ΡΠΈΠ·ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌΡ Π² ΡΠ°Π·Π²ΠΈΡΠΈΠΈ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΏΡΠΎΡΠ΅ΡΡΠ°. ΠΠ·ΡΡΠ°Π»ΠΈΡΡ ΠΌΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌΡ ΡΠ΅Π³ΡΠ»ΡΡΠΈΠΈ Π½Π° ΡΡΠΎΠ²Π½Π΅ ΠΌΠ΅ΠΆΠΊΠ»Π΅ΡΠΎΡΠ½ΡΡ
ΠΌΠ΅Π΄ΠΈΠ°ΡΠΎΡΠΎΠ² ΠΈ Π΄ΡΡΠ³ΠΈΡ
ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΡΡ
ΡΠ°ΠΊΡΠΎΡΠΎΠ² Π½Π° ΠΌΠΎΠ΄Π΅Π»ΡΡ
ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠΈ ΠΏΠ°ΡΠ΅Π½Ρ
ΠΈΠΌΠ°ΡΠΎΠ·Π½ΡΡ
ΠΎΡΠ³Π°Π½ΠΎΠ² (ΠΏΠΎΡΠΊΠΈ, ΠΏΠ΅ΡΠ΅Π½Ρ, ΠΏΠΎΠ΄ΠΆΠ΅Π»ΡΠ΄ΠΎΡΠ½Π°Ρ ΠΆΠ΅Π»Π΅Π·Π°) ΠΈ ΠΊΠΎΡΡΠ½ΠΎΠΉ ΡΠΊΠ°Π½ΠΈ Π² ΡΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠ΅. ΠΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΡ ΠΏΠ΅ΡΠ΅Π½ΠΎΡΠ° ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΡ
Π΄Π°Π½Π½ΡΡ
Π½Π° ΠΎΡΠ³Π°Π½ΠΈΠ·ΠΌ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ° ΡΡΠΎΡΠ½ΡΠ»Π°ΡΡ Π½Π° ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΌ ΠΌΠ°ΡΠ΅ΡΠΈΠ°Π»Π΅. Π£ΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΎ, ΡΡΠΎ ΠΏΡΠΈ ΠΌΠΎΠ΄Π΅Π»ΠΈΡΠΎΠ²Π°Π½ΠΈΠΈ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠΈ ΠΏΠΎΡΠ΅ΠΊ Π½Π°ΡΡΡΠ°ΡΡΡΡ ΠΌΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌΡ ΡΠ΅Π³ΡΠ»ΡΡΠΈΠΈ ΡΠΎΠ΅Π΄ΠΈΠ½ΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΡΠΊΠ°Π½ΠΈ, ΠΊΠΎΡΠΎΡΡΠ΅ ΠΎΡΡΡΠ΅ΡΡΠ²Π»ΡΡΡΡΡ ΡΠΈΡΠΎΠΊΠΈΠ½Π°ΠΌΠΈ, ΡΠ²Π΅Π»ΠΈΡΠΈΠ²Π°ΡΡΡΡ ΡΡΠΎΠ²Π½ΠΈ Π°Π΄ΠΈΠΏΠΎΠΊΠΈΠ½ΠΎΠ², Π°ΠΊΡΠΈΠ²ΠΈΡΡΠ΅ΡΡΡ ΡΠ΅Π³ΡΠ»ΡΡΠΎΡΠ½ΠΎΠ΅ Π·Π²Π΅Π½ΠΎ ΠΊΠΎΡΡΠ½ΠΎΠΉ ΡΠΊΠ°Π½ΠΈ β ΠΏΡΡΡ RANKRANKL-OPG, ΠΈΠΌΠ΅Π΅Ρ ΠΌΠ΅ΡΡΠΎ ΠΏΠΎΠ»ΠΎΠΆΠΈΡΠ΅Π»ΡΠ½Π°Ρ ΠΊΠΎΡΡΠ΅Π»ΡΡΠΈΡ ΠΌΠ΅ΠΆΠ΄Ρ RANKL ΠΈ Π²ΠΈΡΡΠ°ΡΠΈΠ½ΠΎΠΌ (r = 0,48), ΠΏΡΠΎΡΠΈΠ±ΡΠΎΡΠΈΡΠ΅ΡΠΊΠΈΠΌ TGF-Ξ²1 ΠΈ Π°Π΄ΠΈΠΏΠΎΠ½Π΅ΠΊΡΠΈΠ½ΠΎΠΌ (r = 0,47). ΠΠΎΠ΄Π΅Π»ΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠΈ ΠΎΡΠ³Π°Π½ΠΎΠ² ΠΏΠ°Π½ΠΊΡΠ΅Π°ΡΠΎΠ΄ΡΠΎΠ΄Π΅Π½Π°Π»ΡΠ½ΠΎΠΉ Π·ΠΎΠ½Ρ ΠΈ ΡΠΈΠ±ΡΠΎΠ·Π° ΠΏΠ΅ΡΠ΅Π½ΠΈ ΠΏΡΠΈΠ²ΠΎΠ΄ΠΈΡ ΠΊ ΡΠ°Π·Π²ΠΈΡΠΈΡ Π΄Π΅ΡΡΡΡΠΊΡΠΈΠ²Π½ΠΎ-Π΄ΠΈΡΡΡΠΎΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠΉ, Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΡΡ
Π² ΠΏΠ΅ΡΠ΅Π½ΠΈ, ΠΊΠΎΡΠΎΡΡΠ΅ ΡΠΎΠΏΡΠΎΠ²ΠΎΠΆΠ΄Π°ΡΡΡΡ ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΠ΅ΠΌ ΡΠΊΡΠΊΡΠ΅ΡΠΈΠΈ ΠΎΠΊΡΠΈΠΏΡΠΎΠ»ΠΈΠ½Π° Ρ ΠΌΠΎΡΠΎΠΉ Π·Π° ΡΡΠ΅Ρ ΡΠ²ΡΠ·Π°Π½Π½ΠΎΠΉ ΡΡΠ°ΠΊΡΠΈΠΈ. ΠΠ°ΡΡΡΠ΅Π½ΠΈΠ΅ ΡΠ΅ΠΏΠ°ΡΠ°ΡΠΈΠ²Π½ΠΎΠΉ ΡΠ΅Π³Π΅Π½Π΅ΡΠ°ΡΠΈΠΈ ΠΈ Π²ΡΡ
ΠΎΠ΄ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΏΡΠΎΡΠ΅ΡΡΠ° Π½Π° ΡΠΈΡΡΠ΅ΠΌΠ½ΡΠΉ ΡΡΠΎΠ²Π΅Π½Ρ ΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΠ΅ΡΡΡ ΡΠ°ΡΡΡΡΠΎΠΉΡΡΠ²ΠΎΠΌ Π²Π·Π°ΠΈΠΌΠΎΠ΄Π΅ΠΉΡΡΠ²ΠΈΡ ΠΊΠ»Π΅ΡΠΎΠΊ ΡΠΎΠ΅Π΄ΠΈΠ½ΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΡΠΊΠ°Π½ΠΈ Ρ ΡΡΠΎΠΌΠ±ΠΎΡΠΈΡΠ°ΠΌΠΈ. ΠΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌ Π²Π»ΠΈΡΠ½ΠΈΡ ΡΠ΅Π°Π»ΠΈΠ·ΡΠ΅ΡΡΡ ΡΠ΅ΡΠ΅Π· ΡΠΈΡΡΠ΅ΠΌΡ ΡΠΈΡΠΎΠΊΠΈΠ½ΠΎΠ², ΠΊΠΎΡΠΎΡΡΠ΅ ΠΈΠΌΠ΅ΡΡ ΡΠ΅ΡΠ½ΡΠ΅ ΠΊΠΎΡΡΠ΅Π»ΡΡΠΈΠΎΠ½Π½ΡΠ΅ ΡΠ²ΡΠ·ΠΈ Ρ ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎΠΉ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡΡ ΡΡΠΎΠΌΠ±ΠΎΡΠΈΡΠ°ΡΠ½ΠΎΠ³ΠΎ Π·Π²Π΅Π½Π° Π³Π΅ΠΌΠΎΡΡΠ°Π·Π°. ΠΡΠΈ ΠΌΠΎΠ΄Π΅Π»ΠΈΡΠΎΠ²Π°Π½ΠΈΠΈ Π½Π°ΡΡΡΠ΅Π½ΠΈΠΉ ΡΠΎΡΡΠΎΡΠ½ΠΈΡ ΠΊΠΎΡΡΠ½ΠΎΠΉ ΡΠΊΠ°Π½ΠΈ, Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠΈ ΠΎΡΠ³Π°Π½ΠΎΠ² ΠΏΠ°Π½ΠΊΡΠ΅Π°ΡΠΎΠ΄ΡΠΎΠ΄Π΅Π½Π°Π»ΡΠ½ΠΎΠΉ Π·ΠΎΠ½Ρ ΠΈ ΡΠΈΠ±ΡΠΎΠ·Π° ΠΏΠ΅ΡΠ΅Π½ΠΈ ΠΌΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌΡ Π³Π΅ΠΌΠΎΡΡΠ°Π·Π° Π²Π»ΠΈΡΡΡ Π½Π° Π°ΠΊΡΠΈΠ²Π°ΡΠΈΡ ΠΏΡΠΎΠ»ΠΈΡΠ΅ΡΠ°ΡΠΈΠ²Π½ΡΡ
ΠΏΡΠΎΡΠ΅ΡΡΠΎΠ² Π² ΡΠΎΠ΅Π΄ΠΈΠ½ΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΡΠΊΠ°Π½ΠΈ, ΡΡΠΎ ΠΏΡΠΎΡΠ²Π»ΡΠ΅ΡΡΡ ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΠ΅ΠΌ ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎΠΉ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΡΡΠΎΠΌΠ±ΠΎΡΠΈΡΠΎΠ². Π Π³ΡΡΠΏΠΏΠ΅ Π±ΠΎΠ»ΡΠ½ΡΡ
Ρ Π³ΠΈΠ΄ΡΠΎΠ½Π΅ΡΡΠΎΠ·ΠΎΠΌ ΡΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½Π° Π°ΠΊΡΠΈΠ²Π°ΡΠΈΡ ΡΠ΅Π³ΡΠ»ΡΡΠΎΡΠ½ΠΎΠ³ΠΎ ΠΏΡΡΠΈ RANK-RANKL-OPG, ΡΡΠΎ ΡΠ²ΠΈΠ΄Π΅ΡΠ΅Π»ΡΡΡΠ²ΡΠ΅Ρ ΠΎ Π²ΠΎΠ²Π»Π΅ΡΠ΅Π½ΠΈΠΈ ΠΌΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌΠΎΠ² ΡΠ΅Π³ΡΠ»ΠΈΡΠΎΠ²Π°Π½ΠΈΡ Π½Π° ΡΡΠΎΠ²Π½Π΅ ΡΠΈΠ·ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌΡ ΡΠΎΠ΅Π΄ΠΈΠ½ΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΡΠΊΠ°Π½ΠΈ. ΠΡΠ½ΠΎΠ²ΠΎΠΉ ΡΡΠΎΠ³ΠΎ ΠΏΡΠΎΡΠ΅ΡΡΠ° ΡΠ²Π»ΡΠ΅ΡΡΡ Π΄ΠΈΡΠ±Π°Π»Π°Π½Ρ Π² ΡΠΈΡΡΠ΅ΠΌΠ΅ ΡΠΈΡΠΎΠΊΠΈΠ½ΠΎΠ² β IL-1RA, IL-17 ΠΈ Π²ΠΈΡΡΠ°ΡΠΈΠ½Π°, Π° ΡΠ°ΠΊΠΆΠ΅ Π΄ΠΈΡΠ±Π°Π»Π°Π½Ρ (ΠΎΡΡΠΈΡΠ°ΡΠ΅Π»ΡΠ½Π°Ρ ΠΊΠΎΡΡΠ΅Π»ΡΡΠΈΡ) ΠΌΠ΅ΠΆΠ΄Ρ ΡΡΠΎΠ²Π½ΡΠΌΠΈ TGF-Ξ²1 ΠΈ Π°Π΄ΠΈΠΏΠΎΠ½Π΅ΠΊΡΠΈΠ½Π° (r = - 0,29). Π£ Π±ΠΎΠ»ΡΠ½ΡΡ
Ρ ΠΎΠ±ΡΡΡΡΠΊΡΠΈΠ²Π½ΠΎΠΉ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠ΅ΠΉ ΠΏΠ°Π½ΠΊΡΠ΅Π°ΡΠΎΠ΄ΡΠΎΠ΄Π΅Π½Π°Π»ΡΠ½ΠΎΠΉ Π·ΠΎΠ½Ρ ΡΠ°Π·Π²ΠΈΡΠΈΠ΅ ΠΈ ΡΡΠΆΠ΅ΡΡΡ ΠΏΠΎΡΠ»Π΅ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΡΡ
ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠΉ Π·Π°Π²ΠΈΡΡΡ ΠΎΡ ΡΡΠ΅ΠΏΠ΅Π½ΠΈ Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΠΎΡΡΠΈ ΠΈΡΡ
ΠΎΠ΄Π½ΠΎΠ³ΠΎ Π΄ΠΈΡΠ±Π°Π»Π°Π½ΡΠ° ΡΠΈΡΠΎΠΊΠΈΠ½ΠΎΠ²ΠΎΠ³ΠΎ ΠΏΡΠΎΡΠΈΠ»Ρ, Π² ΡΠΎΠΌ ΡΠΈΡΠ»Π΅ ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΡ ΡΡΠΎΠ²Π½Ρ ΠΏΡΠΎΡΠΈΠ²ΠΎΠ²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ Π·Π°ΡΠΈΡΡ. Π Π°Π·Π²ΠΈΡΠΈΠ΅ ΠΎΠ±ΡΡΡΡΠΊΡΠΈΠΈ Π½Π° ΡΠΎΠ½Π΅ Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ ΡΡΠΎΠΉ ΠΎΠ±Π»Π°ΡΡΠΈ ΡΠΎΠΏΡΠΎΠ²ΠΎΠΆΠ΄Π°Π»ΠΎΡΡ ΠΏΠΎΡΠ²Π»Π΅Π½ΠΈΠ΅ΠΌ Π² ΠΊΡΠΎΠ²ΠΈ Π°Π½ΡΠΈΡΠ΅Π» ΠΊ Π°ΡΠΈΠΏΠΈΡΠ½ΡΠΌ ΡΠΎΡΠΌΠ°ΠΌ ΠΊΠΎΠ»Π»Π°Π³Π΅Π½Π°, ΡΡΠΎ ΠΌΠΎΠΆΠ΅Ρ Π²Π΅ΡΡΠΈ ΠΊ Π½Π°ΡΡΡΠ΅Π½ΠΈΡ ΡΠ΅ΠΏΠ°ΡΠ°ΡΠΈΠ²Π½ΠΎΠΉ ΡΠ΅Π³Π΅Π½Π΅ΡΠ°ΡΠΈΠΈ ΠΈ ΡΠ°Π·Π²ΠΈΡΠΈΡ Π°ΡΡΠΎΠΈΠΌΠΌΡΠ½Π½ΡΡ
ΠΏΠΎΠ²ΡΠ΅ΠΆΠ΄Π΅Π½ΠΈΠΉ. ΠΠ° ΠΎΡΠ½ΠΎΠ²Π΅ Π°Π½Π°Π»ΠΈΠ·Π° ΠΊΠΎΡΡΠ΅Π»ΡΡΠΈΠΎΠ½Π½ΡΡ
ΡΠ²ΡΠ·Π΅ΠΉ ΠΈ ΠΌΠ΅ΡΠ°Π°Π½Π°Π»ΠΈΠ·Π° Π΄Π°Π½Π½ΡΡ
ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½Ρ ΡΡΠΈ Π³ΡΡΠΏΠΏΡ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ, ΠΎΡΡΠ°ΠΆΠ°ΡΡΠΈΡ
ΡΡΠ΅ΡΠ΅ΠΎΡΠΈΠΏΠ½ΡΠ΅ ΠΌΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌΡ ΡΠ΅Π³ΡΠ»ΡΡΠΈΠΈ ΡΠΈΠ·ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌΡ ΡΠΎΠ΅Π΄ΠΈΠ½ΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΡΠΊΠ°Π½ΠΈ. ΠΡΡΠΏΠΏΠ° 1 β ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²ΡΠ΅Ρ ΠΌΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌΠ°ΠΌ, ΠΊΠΎΡΠΎΡΡΠ΅ Π΄Π΅ΠΉΡΡΠ²ΡΡΡ Π½Π° ΡΡΠΎΠ²Π½Π΅ ΡΠΈΠ·ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌΡ ΡΠΎΠ΅Π΄ΠΈΠ½ΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΡΠΊΠ°Π½ΠΈ Π² ΡΠ΅Π»ΠΎΠΌ. Π‘ΡΡΠ² ΡΡΠΈΡ
Π°Π΄Π°ΠΏΡΠ°ΡΠΈΠΎΠ½Π½ΡΡ
ΠΌΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌΠΎΠ² Π²Π΅Π΄Π΅Ρ ΠΊ Ρ
ΡΠΎΠ½ΠΈΠ·Π°ΡΠΈΠΈ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΏΡΠΎΡΠ΅ΡΡΠ° ΠΈ ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΡ ΡΠΈΡΠΊΠ° ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠΉ ΠΈ ΡΠ΅ΡΠΈΠ΄ΠΈΠ²ΠΎΠ². Π Π½Π΅ΠΉ ΠΎΡΠ½ΠΎΡΡΡΡΡ ΡΡΠΎΠ²Π½ΠΈ Π²ΠΈΡΡΠ°ΡΠΈΠ½Π°, IL-4, IL-6, TGF-Ξ²1, ΠΌΠ°ΡΡΠ° ΠΈ ΠΏΠ»ΠΎΡΠ½ΠΎΡΡΡ ΠΊΠΎΡΡΠΈ, ΠΏΠ°ΡΠ°ΠΌΠ΅ΡΡΡ Π°Π³ΡΠ΅Π³Π°ΡΠΈΠΈ ΡΡΠΎΠΌΠ±ΠΎΡΠΈΡΠΎΠ² ΠΏΡΠΈ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΈ ΠΈΠ½Π΄ΡΠΊΡΠΎΡΠ° 10 ΠΌΠΊΠΌΠΎΠ»Ρ/Π», ΠΊΠΎΡΠΎΡΡΠ΅ ΡΠ²Π»ΡΡΡΡΡ ΠΎΡΠ½ΠΎΠ²Π½ΡΠΌΠΈ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΡΠΌΠΈ ΠΏΠΎΡΡΠ΅Π΄Π½ΠΈΠΊΠ°ΠΌΠΈ ΡΡΡΠ²Π° Π΅ΡΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΠ³ΠΎ ΡΠ΅ΡΠ΅Π½ΠΈΡ ΡΠ΅ΠΏΠ°ΡΠ°ΡΠΈΠ²Π½ΠΎΠΉ ΡΠ΅Π³Π΅Π½Π΅ΡΠ°ΡΠΈΠΈ. ΠΡΡΠΏΠΏΠ° 2 β ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²ΡΠ΅Ρ ΠΊΠΎΠΌΠΏΠ΅Π½ΡΠ°ΡΠΎΡΠ½ΡΠΌ ΠΌΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌΠ°ΠΌ, Π΄Π΅ΠΉΡΡΠ²ΡΡΡΠΈΠΌ Π½Π° ΡΡΠΎΠ²Π½Π΅ ΡΠΈΠ·ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌΡ ΡΠΎΠ΅Π΄ΠΈΠ½ΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΡΠΊΠ°Π½ΠΈ ΠΏΡΠΈ Π΄ΠΎΡΡΠ°ΡΠΎΡΠ½ΠΎΠΌ ΡΡΠΎΠ²Π½Π΅ ΡΠΈΠ·ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ΅Π·Π΅ΡΠ²ΠΎΠ², ΠΏΡΠΈ ΠΊΠΎΡΠΎΡΠΎΠΌ ΠΏΠΎΠ²ΡΠ΅ΠΆΠ΄Π΅Π½ΠΈΠ΅ Π»ΠΎΠΊΠ°Π»ΠΈΠ·ΠΎΠ²Π°Π½ΠΎ, Π° Π½Π° ΡΠΈΡΡΠ΅ΠΌΠ½ΠΎΠΌ ΡΡΠΎΠ²Π½Π΅ β ΠΊΠΎΠΌΠΏΠ΅Π½ΡΠΈΡΠΎΠ²Π°Π½ΠΎ. Π Π½Π΅Π΅ Π²Ρ
ΠΎΠ΄ΡΡ: ΡΡΠΎΠ²Π½ΠΈ IL-1, IL-1RA, RANKL, ΠΊΠ°Π»ΡΡΠΈΡΠΎΠ½ΠΈΠ½Π° ΠΈ ΠΏΠ°ΡΠ°ΠΌΠ΅ΡΡΡ Π°Π³ΡΠ΅Π³Π°ΡΠΈΠΈ ΡΡΠΎΠΌΠ±ΠΎΡΠΈΡΠΎΠ² ΠΏΡΠΈ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΡΡ
ΠΈΠ½Π΄ΡΠΊΡΠΎΡΠ° 2,5 ΠΈ 10 ΠΌΠΊΠΌΠΎΠ»Ρ/Π». ΠΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΠΈ Π³ΡΡΠΏΠΏΡ 2 ΡΠ²Π»ΡΡΡΡΡ Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ Π·Π½Π°ΡΠΈΠΌΡΠΌΠΈ ΠΊΡΠΈΡΠ΅ΡΠΈΡΠΌΠΈ Π΄Π»Ρ ΠΎΡΠ΅Π½ΠΊΠΈ ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΡ ΡΠΈΡΠΊΠ° ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠΉ Π² Ρ
ΠΎΠ΄Π΅ ΠΌΠΎΠ½ΠΈΡΠΎΡΠΈΠ½Π³Π° Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ. ΠΡΡΠΏΠΏΠ° 3 β ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²ΡΠ΅Ρ ΡΠ΅Π·ΠΊΠΎΠΉ Π°ΠΊΡΠΈΠ²Π°ΡΠΈΠΈ ΠΎΠ±ΠΌΠ΅Π½Π½ΡΡ
ΠΏΡΠΎΡΠ΅ΡΡΠΎΠ² Π½Π° ΡΡΠΎΠ²Π½Π΅ ΡΠΈΠ·ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌΡ ΡΠΎΠ΅Π΄ΠΈΠ½ΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΡΠΊΠ°Π½ΠΈ, ΠΏΡΠΈ ΠΊΠΎΡΠΎΡΡΡ
Π·Π°Π΄Π΅ΠΉΡΡΠ²ΠΎΠ²Π°Π½ΠΎ Π±ΠΎΠ»ΡΡΠΈΠ½ΡΡΠ²ΠΎ ΠΏΡΡΠ΅ΠΉ ΡΠ΅Π³ΡΠ»ΠΈΡΠΎΠ²Π°Π½ΠΈΡ, ΡΠΎ ΡΠΌΠ΅ΡΠ΅Π½ΠΈΠ΅ΠΌ Π² ΡΡΠΎΡΠΎΠ½Ρ ΠΏΡΠ΅ΠΎΠ±Π»Π°Π΄Π°Π½ΠΈΡ ΡΠΈΠ½ΡΠ΅Π·Π° Π½Π°Π΄ ΡΠ°ΡΠΏΠ°Π΄ΠΎΠΌ. ΠΡΡΠΏΠΏΠ° 3 ΠΎΠ±ΡΠ΅Π΄ΠΈΠ½ΡΠ΅Ρ ΡΡΠΎΠ²Π½ΠΈ IL-17, OPG, RANKL, Π°Π΄ΠΈΠΏΠΎΠ½Π΅ΠΊΡΠΈΠ½Π°, ΠΏΠ°ΡΠ°ΡΠΈΡΠ΅ΠΎΠΈΠ΄Π½ΠΎΠ³ΠΎ Π³ΠΎΡΠΌΠΎΠ½Π°, Π²ΡΠ΅Ρ
ΡΡΠ°ΠΊΡΠΈΠΉ ΠΎΠΊΡΠΈΠΏΡΠΎΠ»ΠΈΠ½Π° ΠΈ ΠΏΠ°ΡΠ°ΠΌΠ΅ΡΡΠΎΠ² Π°Π³ΡΠ΅Π³Π°ΡΠΈΠΈ ΡΡΠΎΠΌΠ±ΠΎΡΠΈΡΠΎΠ² ΠΏΡΠΈ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΡΡ
ΠΈΠ½Π΄ΡΠΊΡΠΎΡΠ° 2,5 ΠΈ 5 ΠΌΠΊΠΌΠΎΠ»Ρ/Π». ΠΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΠΈ ΡΡΠΎΠΉ Π³ΡΡΠΏΠΏΡ Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ ΠΈΠ½ΡΠΎΡΠΌΠ°ΡΠΈΠ²Π½Ρ Π΄Π»Ρ ΠΎΡΠ΅Π½ΠΊΠΈ Π²ΠΎΠ²Π»Π΅ΡΠ΅Π½Π½ΠΎΡΡΠΈ ΡΠΈΠ·ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌΡ ΡΠΎΠ΅Π΄ΠΈΠ½ΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΡΠΊΠ°Π½ΠΈ Π² ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΉ ΠΏΡΠΎΡΠ΅ΡΡ Π½Π° ΡΠ°Π½Π½ΠΈΡ
ΡΡΠ°Π΄ΠΈΡΡ
Π΅Π³ΠΎ ΡΠ°Π·Π²ΠΈΡΠΈΡ, Π²ΠΊΠ»ΡΡΠ°Ρ Π΄ΠΎΠ½ΠΎΠ·ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΡΠΎΡΡΠΎΡΠ½ΠΈΡ. ΠΡΠΈ Π·Π½Π°ΡΠΈΡΠ΅Π»ΡΠ½ΡΡ
ΠΎΠ±ΡΠ΅ΠΌΠ°Ρ
ΠΏΠΎΠ²ΡΠ΅ΠΆΠ΄Π΅Π½ΠΈΡ ΠΈ Π΄Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ Π²ΡΡΠ²Π»ΡΠ΅ΡΡΡ Π²ΠΎΠ²Π»Π΅ΡΠ΅Π½ΠΈΠ΅ Π² ΡΠ°Π·Π²ΠΈΡΠΈΠ΅ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΏΡΠΎΡΠ΅ΡΡΠ° ΡΠΈΠ·ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌΡ ΡΠΎΠ΅Π΄ΠΈΠ½ΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΡΠΊΠ°Π½ΠΈ Π² ΡΠ΅Π»ΠΎΠΌ, ΡΠΎ Π΅ΡΡΡ Π΅Π΅ ΡΠ΅Π°ΠΊΡΠΈΡ Π½Π°ΡΡΠ΄Ρ Ρ ΡΠ΅Π°ΠΊΡΠΈΡΠΌΠΈ Π΄ΡΡΠ³ΠΈΡ
ΠΎΡΠ³Π°Π½ΠΎΠ² ΠΈ ΡΠΈΡΡΠ΅ΠΌ ΠΏΡΠΈ Π²ΠΎΡΠΏΠ°Π»Π΅Π½ΠΈΠΈ ΡΠ²Π»ΡΠ΅ΡΡΡ ΠΎΠ΄Π½ΠΈΠΌ ΠΈΠ· Π²Π°ΠΆΠ½ΡΡ
ΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½ΡΠΎΠ² ΡΠΈΠ½Π΄ΡΠΎΠΌΠ° ΡΠΈΡΡΠ΅ΠΌΠ½ΠΎΠ³ΠΎ Π²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΠΎΡΠ²Π΅ΡΠ° (SIRS). Π Π·Π°Π²ΠΈΡΠΈΠΌΠΎΡΡΠΈ ΠΎΡ ΡΠ΅Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΠΎΡΠ³Π°Π½ΠΈΠ·ΠΌΠ° ΠΈ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠ΅ΠΉ ΠΏΠΎΠ²ΡΠ΅ΠΆΠ΄Π΅Π½ΠΈΡ ΠΈΠ·ΠΌΠ΅Π½ΡΠ΅ΡΡΡ Ρ
ΠΎΠ΄ ΠΏΡΠΎΡΠ΅ΡΡΠ° ΠΈ ΡΡΠ΅ΠΏΠ΅Π½Ρ Π²ΠΎΠ²Π»Π΅ΡΠ΅Π½ΠΈΡ ΡΠΈΡΡΠ΅ΠΌΡ ΡΠΎΠ΅Π΄ΠΈΠ½ΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΡΠΊΠ°Π½ΠΈ, ΡΡΠΎ ΡΠ²Π»ΡΠ΅ΡΡΡ Π²Π°ΠΆΠ½ΡΠΌ ΡΠ°ΠΊΡΠΎΡΠΎΠΌ Ρ
ΡΠΎΠ½ΠΈΠ·Π°ΡΠΈΠΈ ΠΈ ΡΠΈΡΠΊΠ° ΡΠ΅ΡΠΈΠ΄ΠΈΠ²ΠΈΡΠΎΠ²Π°Π½ΠΈΡ. ΠΠΎΠΊΠ°Π·Π°Π½ΠΎ Π·Π½Π°ΡΠ΅Π½ΠΈΠ΅ ΡΡΠ΅ΠΏΠ΅Π½ΠΈ Π²ΠΎΠ²Π»Π΅ΡΠ΅Π½ΠΈΡ ΡΠΎΠ΅Π΄ΠΈΠ½ΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΡΠΊΠ°Π½ΠΈ ΠΈ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠ°Ρ ΡΠ΅Π½Π½ΠΎΡΡΡ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ Π΅Ρ ΠΎΠ±ΠΌΠ΅Π½Π° (ΠΎΠΊΡΠΈΠΏΡΠΎΠ»ΠΈΠ½Π° ΠΈ Π³Π»ΠΈΠΊΠΎΠ·Π°ΠΌΠΈΠ½ΠΎΠ³Π»ΠΈΠΊΠ°Π½ΠΎΠ²) Π΄Π»Ρ ΡΠ°Π½Π½Π΅ΠΉ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ Π½Π΅ΡΡΠΎΡΠΊΠ»Π΅ΡΠΎΠ·Π° Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΌ ΠΏΠΈΠ΅Π»ΠΎΠ½Π΅ΡΡΠΈΡΠΎΠΌ, ΡΠ΅Π½Π°Π»ΡΠ½ΠΎΠΉ ΠΎΡΡΠ΅ΠΎΠ΄ΠΈΡΡΡΠΎΡΠΈΠΈ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
Ρ Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΠΎΡΠ΅ΡΠ½ΠΎΠΉ Π½Π΅Π΄ΠΎΡΡΠ°ΡΠΎΡΠ½ΠΎΡΡΡΡ, ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΡΠΎΡΠ΅ΡΡΠΎΠ² ΡΠ°Π·Π½ΠΎΠΉ ΠΈΠ½ΡΠ΅Π½ΡΠΈΠ²Π½ΠΎΡΡΠΈ Π² ΠΆΠ΅Π»ΡΠ΄ΠΊΠ΅; ΡΠΎΠ»Ρ ΠΌΠ΅ΠΆΠΊΠ»Π΅ΡΠΎΡΠ½ΡΡ
ΠΌΠ΅Π΄ΠΈΠ°ΡΠΎΡΠΎΠ² Π² ΠΌΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌΠ΅ ΡΠ΅ΠΏΠ°ΡΠ°ΡΠΈΠ²Π½ΠΎΠΉ ΡΠ΅Π³Π΅Π½Π΅ΡΠ°ΡΠΈΠΈ Ρ ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ² Ρ Π΄ΡΠΎΠ΄Π΅Π½Π°Π»ΡΠ½ΠΎΠΉ ΡΠ·Π²ΠΎΠΉ, Ρ Π΄Π΅ΡΠ΅ΠΉ Ρ ΠΊΠ°ΡΠ΄ΠΈΠΎΠΏΠ°ΡΠΈΠ΅ΠΉ ΠΈ ΠΎΡΡΠ΅ΠΎΠΏΠ΅Π½ΠΈΠ΅ΠΉ Π½Π° ΡΠΎΠ½Π΅ Π½Π΅Π΄ΠΈΡΡΠ΅ΡΠ΅Π½ΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ Π΄ΠΈΡΠΏΠ»Π°Π·ΠΈΠΈ ΡΠΎΠ΅Π΄ΠΈΠ½ΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΡΠΊΠ°Π½ΠΈ. ΠΠΎΠΊΠ°Π·Π°Π½Π° Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΡ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ ΠΎΠΊΡΠΈΠΏΡΠΎΠ»ΠΈΠ½Π°, Π³Π»ΠΈΠΊΠΎΠ·Π°ΠΌΠΈΠ½ΠΎΠ³Π»ΠΈΠΊΠ°Π½ΠΎΠ² ΠΈ Π°Π½ΡΠΈΡΠ΅Π» ΠΊ Π°ΡΠΈΠΏΠΈΡΠ½ΡΠΌ ΡΠΎΡΠΌΠ°ΠΌ ΠΊΠΎΠ»Π»Π°Π³Π΅Π½Π° Π² ΠΊΠ°ΡΠ΅ΡΡΠ²Π΅ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΡΡ
ΠΌΠ°ΡΠΊΠ΅ΡΠΎΠ² Π΄Π»Ρ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ Π΄ΠΎΠ½ΠΎΠ·ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠΎΡΡΠΎΡΠ½ΠΈΠΉ ΠΈ ΠΎΡΠ΅Π½ΠΊΠΈ ΠΏΠΎΠΏΡΠ»ΡΡΠΈΠΎΠ½Π½ΠΎΠ³ΠΎ Π·Π΄ΠΎΡΠΎΠ²ΡΡ.Dissertation is devoted to solving the urgent problem of establishing the role of the stereotypical reactions of connective tissue as a physiological system in the development of the pathological processes. General principles for the assessment of the physiological system of connective tissue are formulated, and its role in the development of the pathological processes in the parenchymatous organs (kidney, liver, pancreas) and bone is determined. We first studied the role of regulatory path RANK-RANKL-OPG in experimental modeling of renal diseases, its activation and the relationship with pro- and anti-inflammatory cytokines, including a positive correlation between RANKL and profibrogenic TGF-Ξ²1 (r = 0,61). New pathogenetic mechanisms of disturbances of condition of bone tissue are identified and development of fibrosis of the liver and pancreas, associated with a decrease in the functional activity of platelets is made. It is established that the hemostasis mechanisms influence the activation of proliferative processes in the connective tissue. Possibility of transferring the data on the person was specified on the clinical material. Role of the state of the physiological system of connective tissue in the development of complications and recurrences in patients with hydronephrotic transformation of the kidneys is detected; activation regulatory path RANKRANKL-OPG in patients with hydronephrosis is established. Interrelation of the various mechanisms of regulation of the physiological system of connective tissue in the development of pathology of the pancreatoduodenal zonesβ organs is shown. Based on the assessment of the physiological system of connective tissue the methods for predicting surgical complications and recurrence of the disease are proposed. Conducted meta-analysis of the obtained data, on the basis of which with the help of factor analysis, the main groups of indicators (factors) are established, which reflect the main directions of the pathological process, mediated reactions in physiological system of the connective tissue. Augmented scientific data on the mechanisms of chronization of the pathological process in diseases of the kidneys is supplemented; it is shown that changes of the functional state of the connective tissue can be quantitatively recorded even in the case of a sluggish pathological process in the small mass organ. Augmented scientific data on the role and degree of involvement of the regulatory function damages of the physiological system of connective tissue in the development of diseases of the gastrointestinal tract, including duodenal ulcer is supplemented. Role and significance of the decline in physiological reserves of the physiological system of connective tissue to increase the risk of morbidity in the population is shown. Method of risk assessment for population health based on the analysis of physiological reserves of the physiological system of the connective tissue is proposed
Visualization and Quantitative Analysis of G Protein-Coupled ReceptorβΞ²-Arrestin Interaction in Single Cells and Specific Organs of Living Mice Using Split Luciferase Complementation
Methods used to assess the efficacy of potentially therapeutic
reagents for G protein-coupled receptors (GPCRs) have been developed.
Previously, we demonstrated sensitive detection of the interaction
of GPCRs and Ξ²-arrestin2 (ARRB2) using 96-well microtiter plates
and a bioluminescence microscope based on split click beetle luciferase
complementation. Herein, using firefly luciferase emitting longer
wavelength light, we demonstrate quantitative analysis of the interaction
of Ξ²2-adrenergic receptor (ADRB2), a kind of GPCR, and ARRB2
in a 96-well plate assay with single-cell imaging. Additionally, we
showed bioluminescence <i>in vivo</i> imaging of the ADRB2βARRB2
interaction in two systems: cell implantation and hydrodynamic tail
vein (HTV) methods. Specifically, in the HTV method, the luminescence
signal from the liver upon stimulation of an agonist for ADRB2 was
obtained in the intact systems of mice. The results demonstrate that
this method enables noninvasive screening of the efficacy of chemicals
at the specific organ in <i>in vivo</i> testing. This <i>in vivo</i> system can contribute to effective evaluation in
pharmacokinetics and pharmacodynamics and expedite the development
of new drugs for GPCRs
Fluorescent Probes for Imaging Endogenous Ξ²-Actin mRNA in Living Cells Using Fluorescent Protein-Tagged Pumilio
Subcellular localization and dynamics of mRNAs control
various
physiological functions in living cells. A novel technique for visualizing
endogenous mRNAs in living cells is necessary for investigation of
the spatiotemporal movement of mRNAs. A pumilio homology domain of
human pumilio 1 (PUM-HD) is a useful RNA binding protein as a tool
for mRNA recognition because the domain can be modified to bind a
specific 8-base sequence of target mRNA. In this study, we designed
PUM-HD to match the sequence of Ξ²-actin mRNA and developed an
mRNA probe consisting of two PUM-HD mutants flanking full-length enhanced
green fluorescent protein (EGFP). Fluorescence microscopy with the
probe in living cells revealed that the probe was labeled precisely
with the Ξ²-actin mRNA in cytosol. Fluorescent spots from the
probe were colocalized with microtubules and moved directionally in
living cells. The PUM-HD mutants conjugated with full-length EGFP
can enable visualization of Ξ²-actin mRNA localization and dynamics
in living cells
Measuring CREB Activation Using Bioluminescent Probes That Detect KIDβKIX Interaction in Living Cells
The cyclic adenosine monophosphate response element-binding
protein
(CREB) is a transcription factor that contributes to memory formation.
The transcriptional activity of CREB is induced by its phosphorylation
at Ser-133 and subsequent interaction with the CREB-binding protein
(CBP)/p300. We designed and optimized firefly split luciferase probe
proteins that detect the interaction of the kinase-inducible domain
(KID) of CREB and the KIX domain of CBP/p300. The increase in the
light intensity of the probe proteins results from the phosphorylation
of the responsible serine corresponding to Ser-133 of CREB. Because
these proteins have a high signal-to-noise ratio and are nontoxic,
it has become possible for the first time to carry out long-term measurement
of KIDβKIX interaction in living cells. Furthermore, we examined
the usefulness of the probe proteins for future high-throughput cell-based
drug screening and found several herbal extracts that activated CREB
Simultaneous Time-Lamination Imaging of Protein Association Using a Split Fluorescent Timer Protein
Studies of temporal behaviors of
protein association in living
cells are crucially important for elucidating the fundamental roles
and the mechanism of interactive coordination for cell activities.
We developed a method for investigating the temporal alternation of
a particular protein assembly using monomeric fluorescent proteins,
fluorescent timers (FTs), of which the fluorescent color changes from
blue to red over time. We identified a dissection site of the FTs,
which allows complementation of the split FT fragments. The split
fragments of each FT variant recovered their fluorescence and maintained
inherent rates of the color changes upon the reassembly of the fragments
in vitro. We applied this method to visualize the aggregation process
of Ξ±-synuclein in living cells. The size of the aggregates with
the temporal information was analyzed from ratio values of the blue
and red fluorescence of the reconstituted FTs, from which the aggregation
rates were evaluated. This method using the split FT fragments enables
tracing and visualizing temporal alternations of various protein associations
by single fluorescence measurements at a given time point
Bioluminescent Indicator for Highly Sensitive Analysis of Estrogenic Activity in a Cell-Based Format
Estrogens
regulate different physiological systems with wide ranges
of concentrations. The rapid analysis of estrogens is crucially important
for drug discovery and medical diagnosis, but quantitation of nanomolar
estrogens in live cells persists as an important challenge. We herein
describe a bioluminescent indicator used to detect low concentrations
of estrogens quantitatively with a high signal-to-background ratio.
The indicator comprises a ligand-binding domain of an estrogen receptor
connected with its binding peptide, which is sandwiched between split
fragments of a luciferase mutant. Results show that the indicator
recovered its bioluminescence upon binding to 17Ξ²-estradiol
at concentrations higher than 1.0 Γ 10<sup>β10</sup> M.
The indicator was reactive to agonists but did not respond to antagonists.
The indicator is expected to be applicable for rapid screening estrogenic
compounds and inhibitors, facilitating the discovery of drug candidates
in a high-throughput manner
Spectral Mining for Discriminating Blood Origins in the Presence of Substrate Interference via Attenuated Total Reflection Fourier Transform Infrared Spectroscopy: Postmortem or Antemortem Blood?
Often
in criminal investigations, discrimination of types of body
fluid evidence is crucially important to ascertain how a crime was
committed. Compared to current methods using biochemical techniques,
vibrational spectroscopic approaches can provide versatile applicability
to identify various body fluid types without sample invasion. However,
their applicability is limited to pure body fluid samples because
important signals from body fluids incorporated in a substrate are
affected strongly by interference from substrate signals. Herein,
we describe a novel approach to recover body fluid signals that are
embedded in strong substrate interferences using attenuated total
reflection Fourier transform infrared (ATR FT-IR) spectroscopy and
an innovative multivariate spectral processing. This technique supported
detection of covert features of body fluid signals, and then identified
origins of body fluid stains on substrates. We discriminated between
ATR FT-IR spectra of postmortem blood (PB) and those of antemortem
blood (AB) by creating a multivariate statistics model. From ATR FT-IR
spectra of PB and AB stains on interfering substrates (polyester,
cotton, and denim), blood-originated signals were extracted by a weighted
linear regression approach we developed originally using principal
components of both blood and substrate spectra. The blood-originated
signals were finally classified by the discriminant model, demonstrating
high discriminant accuracy. The present method can identify body fluid
evidence independently of the substrate type, which is expected to
promote the application of vibrational spectroscopic techniques in
forensic body fluid analysis
Bioluminescent Probes to Analyze Ligand-Induced Phosphatidylinositol 3,4,5-Trisphosphate Production with Split Luciferase Complementation
A lipid second messenger, phosphatidylinositol
(3,4,5)-trisphosphate (PIP<sub>3</sub>), is a signaling molecule that
mediates central cellular events, such as growth, motility, and development
by activating downstream proteins. Although functions of various PIP<sub>3</sub> binding partners have been unveiled, the various roles of
PIP<sub>3</sub> have not been resolved thoroughly because of limitations
of PIP<sub>3</sub> analysis. Herein, we describe a novel method for
the analysis of relative PIP<sub>3</sub> amount based on spontaneous
complementation of split luciferase fragments. An N-terminal fragment
of a luciferase was located on the plasma membrane (LucN-pm). A C-terminal
fragment of a luciferase fused with PIP<sub>3</sub> binding units,
pleckstrin homology domains (PHDs) of the general receptor for phosphoinositides
1 (GRP1), was expressed in cytosol (PP-LucC). In response to PIP<sub>3</sub> production, PP-LucC was brought to the plasma membrane and
colocalized with LucN-pm. The LucN-pm and PP-LucC reconstituted spontaneously
to form an active luciferase, producing bioluminescence recovery.
We obtained bioluminescence signals corresponding to relative PIP<sub>3</sub> amounts successfully upon stimulation with an agonist. We
also demonstrated that the probes were applied for a high-throughput
screening format and for monitoring of PIP<sub>3</sub> production
on the plasma membrane by bioluminescence. This method enables further
study of PIP<sub>3</sub> and supports versatile applications related
to the PIP<sub>3</sub> amount
MOESM1 of Rapid in vivo lipid/carbohydrate quantification of single microalgal cell by Raman spectral imaging to reveal salinity-induced starch-to-lipid shift
Additional file 1: Figure S1. The stability test of our Raman setup over 6 hourβs measurement. Figure S2. The raw data without fluorescence background subtraction calculations for the data shown in Fig.Β 2. Figure S3. The TEM images of microalgal cells under different stress conditions
Heat shock factor 1 (HSF1) interacts with BMAL1:CLOCK after the heat shock (HS) pulse.
<p>Wild-type (WT) mouse embryonic fibroblasts (MEFs) were treated with or without an HS pulse. At 24 h after the HS pulse, the lysates were subjected to immunoblotting for PER2, HSP70, BMAL1, HSF1, and actin. Representative images from triplicate independent experiments are shown (<b>A</b>). WT and <i>Hsf1</i><sup>β/β</sup> MEFs were treated with the HS pulse. At the indicated times after the HS pulse, the lysates (<b>B</b>) and BMAL1/HSF1 immunoprecipitates (<b>D; CoIP</b>) were subjected to immunoblotting for PER2, HSP70, BMAL1, HSF1, CLOCK, and actin. Representative images from triplicate independent experiments are shown. Normalized PER2 and HSP70 protein levels (<b>B</b>; at 26 h after the HS pulse), and BMAL1 coimmunoprecipitated with HSF1 and CLOCK (<b>D</b>) are shown as average values from triplicate independent experiments. Error bars indicate standard deviation (SD) (*** P<0.001). (<b>C</b>) WT and <i>Hsf1</i><sup>β/β</sup> MEFs were treated with the HS pulse. At the indicated times after the HS pulse, the lysates were subjected to immunoblotting for PER2, HSP70, BMAL1, HSF1, and actin. Representative images from triplicate independent experiments are shown. Normalized circadian PER2 and HSP70 protein profiles plotted with average values from triplicate independent experiments are shown and error bars indicate SD.</p